Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival

Journal of Clinical Oncology

Volumn 20, Issue 19, 2002, Pages 4040-4049

  Smith, Thomas J ^a   Staats, Peter S ^a   Deer, Timothy ^a   Stearns, Lisa J ^a   Rauck, Richard L ^a   Boortz Marx, Richard L ^a   Buchser, Eric ^a   Català, Elena ^a   Bryce, David A ^a   Coyne, Patrick J ^a   Pool, George E ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; CLONIDINE; HYDROMORPHONE; MORPHINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; AMNESIA; ANALGESIA; ANOREXIA; ARTICLE; CANCER CENTER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFUSION; CONSCIOUSNESS DISORDER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; FATIGUE; FEMALE; HUMAN; IMPOTENCE; INFUSION PUMP; INTERMETHOD COMPARISON; LIBIDO; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT CARE; PERSONALITY DISORDER; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TOXICITY; TREATMENT OUTCOME; URTICARIA; VISUAL ANALOG SCALE; VOMITING; WEIGHT REDUCTION;

EID: 0036789538     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.02.118     Document Type: Article

References (30)

1. Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596, 1994
2. Vainio A, Auvinen A: Prevalence of symptoms among patients with advanced cancer: An international collaborative study - Symptom Prevalence Group. J Pain Symptom Manage 12:3-10, 1996
3. Lamer T: Treatment of cancer-related pain: When orally administered medications fail. Mayo Clin Proc 69:473-480, 1994
4. Staats P: Neuraxial infusion for pain control: When, why, and what to do after the implant. Oncology 13:58-62, 1999
5. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KL, Grond S: Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93:247-257, 2001
6. O'Mahony S, Coyle N, Payne R: Current management of opioid-related side effects. Oncology 15:61-82, 2001
7. Miaskowski C, Dodd MJ, West C, et al: Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. J Clin Oncol 19:4275-4279, 2001
8. DeVulder J, Ghys L, Dhondt W, Rolly G: Spinal analgesia in terminal care: Risk versus benefit. J Pain Symptom Manage 9:75-81, 1994
9. Hassenbusch S, Pillay P, Magdinec M, et al: Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg 73:405-409, 1990
10. Onofrio B, Yaksh T: Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 72:200-209, 1990
11. Penn R, Paice J: Chronic intrathecal morphine for intractable pain. J Neurosurg 67:182-186, 1987
12. Jacox A, Carr D, Payne R, et al: Management of Cancer Pain: Clinical Practice Guideline no 9. Rockville, MD, AHCPR publication 94-0592, 1994
13. Brown M, Glick H, Harrell F, et al: Integrating economic analysis into cancer clinical trials: The NCI-ASCO economics workbook. J Natl Cancer Inst 24:1-28, 1998
14. Egger M, Juni P, Barlett C: CONSORT Group (Consolidated Standards of Reporting of Trials): Value of flow diagrams in reports of randomized controlled trials. JAMA 285:1996-1999, 2001
15. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995
16. DuPen S, DuPen A, Polossar N, et al: Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 17:361-370, 1999
17. McQuay HJ, Moore RA, Eccleston C, Morley S, Williams AC: Systematic review of outpatient services for chronic pain control. Health Technol Assess 1:1-135, 1997
18. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL: Defining the clinically important difference in pain outcome measures. Pain 88:287-294, 2000
19. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149-158, 2001
20. Portenoy RK, Savage SR: Clinical realities and economic considerations: Special therapeutic issues in intrathecal therapy-tolerance and addiction. J Pain Symptom Manage 14:S27-S35, 1997
21. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D: Will to live in the terminally ill. Lancet 354:816-819, 1999
22. von Tempelhoff GF, Harenberg J, Niemann F, Hommel G, Kirkpatrick CJ, Heilmann L: Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast a pelvic cancer surgery: A prospective randomized double-blind trial. Int J Oncol 16:815-824, 2000
23. Littlewood TJ, Bajetta E, Nortier JWR, Vercammen E, Rapoport B: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19: 2865-2874, 2001
24. Staats PS: The pain-mortality link: Unraveling the mysteries, in Payne R, Patt RH, Hill CS (eds): Assessment and Treatment of Cancer Pain: Progression in Pain Research and Management. Seattle, WA, IASP Press, 1998, pp 145-156
25. Lillemoe K, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK: Chemical splanchnicectomy in patients with unresectable pancreatic cancer: A prospective randomized trial. Ann Surg 217:447-455, 1993
26. Staats P, Hekmat H, Sauter P, Lillemoe K: The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: A double-blind, randomized, placebo-controlled study. Pain Med 2:28-34, 2001
27. Hillner BE, Smith TJ, Desch CE: Outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 18:2327-2340, 2000
28. Smith TJ, Hillner BE: Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 19: 2886-2897, 2001
29. Christakis NA, Lamont EB: Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 320:469-473, 2000
30. Smith TJ, Hillner BE, Desch CE: Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Natl Cancer Inst 85:1460-1474, 1993